LRRC8C and idiopathic pulmonary fibrosis: In vitro assays, consistent with bioinformatics analysis of IPF progression in context: CTD-2528L19.6 was proven to alleviate fibroblast activation by regulating LRRC8C in MRC-5 cells and the silencing CTD-2528L19.6 promoted pulmonary fibrosis.